Explore Zepbound's "Changing the Threads" exhibit, which is redefining the stigma of obesity through powerful stories and ...

The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli Lilly might soon join them for a ...

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

Tan France teased what fans can expect from the tenth — and final! — season of Queer Eye, admitting he got emotional when ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...

When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The ...

Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, ...

American Express is an advertising partner of Motley Fool Money. The Motley Fool has positions in and recommends Amazon, Peloton Interactive, and Pfizer. The Motley Fool recommends Coinbase Global and ...

"Developing new ways to treat these patients is of the utmost importance," Dr. Casey H. Halpern, a senior author of the study ...